How Has the Mitral Valve Disease Market Size Evolved in Recent Years?
The mitral valve disease market has seen considerable growth due to a variety of factors.
• The mitral valve disease market has experienced strong growth in recent years. It will rise from $3 billion in 2024 to $3.3 billion in 2025, at a CAGR of 9.8%.
This growth is driven by patient education initiatives, better reimbursement policies, increasing healthcare expenditure, higher awareness, and expanded market presence.
What are the Market Size and Expected Growth Rates for the Mitral Valve Disease Market?
The mitral valve disease market is expected to maintain its strong growth trajectory in upcoming years.
• The mitral valve disease market is expected to grow robustly, reaching $4.73 billion by 2029 at a CAGR of 9.4%.
The growth is driven by the rising prevalence of mitral valve disease, increasing adoption of minimally invasive techniques, innovations in heart valve surgery, and growing interest from manufacturers. Key trends include advancements in transcatheter technologies and surgical procedures.
Which Key Drivers Are Propelling The Mitral Valve Disease Market's Growth?
The increasing prevalence of vascular heart diseases is expected to drive the growth of the mitral valve disease market. Vascular heart diseases involve conditions that affect the blood vessels around the heart. These diseases can lead to mitral valve problems by impacting the heart's structure and function. For example, in 2024, the Australian Bureau of Statistics reported an increase in cardiovascular disease deaths in 2022. The growing prevalence of vascular heart diseases is thus fueling the mitral valve disease market.
What Are The Key Segments Within The Global Mitral Valve Disease Market?
The mitral valve disease market covered in this report is segmented –
1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair
2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)
3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing
4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices
Pre-Book The Mitral Valve Disease Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Mitral Valve Disease Industry?
Leading businesses in the mitral valve disease market are innovating stented tissue valves in response to the rising demand for less invasive treatment solutions. These valves are engineered to offer robust and dependable functionality, setting up an option to conventional surgical procedures. For example, Medtronic, a healthcare firm originating from Ireland, unveiled the Avalus Ultra valve in April 2024. This sophisticated surgical aortic tissue valve is crafted for improved implantation ease and extended patient care. Leveraging ten years of clinical know-how with the original Avalus valve, the Avalus Ultra is equipped with a low valve profile for simpler implantation, PEEK base frame for maintaining circular shape and a top-tier Effective Orifice Area (EOA) that could enhance blood circulation. Also included is a radiopaque coil, designed for unambiguous visibility during prospective valve-in-valve surgeries.
Who Are the Key Players In The Mitral Valve Disease Market?
Major companies operating in the mitral valve disease market are:
• Pfizer Inc.
• Bayer AG
• Abbott Laboratories
• Novartis AG
• Medtronic plc
• Boston Scientific Corporation
• Edwards Lifesciences
• ShockWave Medical Inc.
• Artivion Inc.
• TTK Health Care Limited
• Braile Biomedica
• JenaValve Technology Inc.
• 4C Medical technologies
• Labcor Laboratorios Ltda
• CryoLife Inc.
• Valcare Medical
• Affluent Medical
• Colibri Heart Valve LLC
• Coramaze Technologies
• Corcym UK Limited
• HighLife Medical
• Micro International Devices Inc.
• Neovasc Inc.
• Mitralign Inc.
• Transcatheter Technologies GmbH
What Are The Regional Insights Into The Mitral Valve Disease Market?
Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
